|
|
| Industrie Pharmaceutique > Etude de marché sectorielle |
| Global Pharmaceuticals, Biotechnology & Life Sciences |
|
|
|
|
€ 160,00 |
Editeur
: |
Datamonitor |
Langue
: |
Anglais |
Date de publication : |
Avril 2006 |
Taille du document : |
14 |
Autres informations : |
Description , Table des matières |
| |
|
|
|
|
| |
Documents Publics |
1,200,000
documents |
Téléchargement illimités |
|
|
|
Etudes Privées |
50,000 rapports et études |
Paiement à la piéce |
|
|
|
|
| |
|
1.Télécharger nos rapports publics
Accés complet à plus de 1,2 Million de documents publics : études de marché, statistiques sectorielles, fiches pays, monographie d'entreprises, veille concurentielle, rapports annuels...
|
| Nos documents publics sur le même théme (5) |
|
|
|
| 228 pages | Mars 2005 | Anglais
|
|
|
| Main
focus: |
life sciences,architectural services
|
| Research
focus: |
competition analysis,advertising, |
| Geographic
focus: |
usa |
| |
|
|
|
|
| 623 pages | Janvier 2005 | Anglais
|
|
|
| Main
focus: |
life sciences,architectural services
|
| Research
focus: |
competition analysis,advertising, |
| Geographic
focus: |
usa |
| |
|
|
|
|
| 431 pages | Mai 2005 | Anglais
|
|
|
| Main
focus: |
life sciences,architectural services
|
| Research
focus: |
competition analysis,advertising, |
| Geographic
focus: |
usa |
| |
|
|
|
|
| 660 pages | Janvier 2005 | Anglais
|
|
|
| Main
focus: |
life sciences,health care,architectural services
|
| Research
focus: |
competition analysis,advertising, |
| Geographic
focus: |
usa,canada,mexico,united kingdom |
| |
|
|
|
|
| 432 pages | Mai 2005 | Anglais
|
|
|
| Main
focus: |
life sciences,health care,architectural services
|
| Research
focus: |
competition analysis,advertising, |
| Geographic
focus: |
usa,canada,mexico,united kingdom |
| |
|
|
|
|
| Autres recherches sur le même thème |
|
|
|
| |
| |
|
| |
|
2.
Rechercher d'autres rapports et études à commander
Rechercher et commander ici parmi 50.000 études de marché publiées par les principaux instituts d'études internationaux
|
| Rapports privés en relation |
|
Pharmaceutical Pricing Strategies
121 pages | Juillet 1998 |
Which pricing strategies will enable your company to maximise profitability? As healthcare cost-containment intensifies and pricing freedom is eroded, the need to develop new strategies to mainta |
795,00 €
|
| |
| |
Pharmaceutical Pricing Strategies 2000: Entering the new millennium
240 pages | Juin 2000 |
The favorable climate of the pharmaceutical sector has changed radically over the past ten years.
Where once a company's freedom over pricing decisions was almost limitless, external pressure |
955,00 €
|
| |
| |
Pain Therapeutics: A Strategic Re-evaluation.
198 pages | Août 2000 |
Pain management, though not a life-threatening disease, will have its proper place in the future healthcare system because the disability and economic loss in addition to personal suffering caused |
955,00 €
|
| |
| |
European Pharmaceutical Industry
35 pages | Juillet 2002 |
The Pharmaceutical industry remains one of Europe’s best performing sectors (employment, R&D and trade surplus).
The world pharmaceutical market was worth an estimated € 392,640 million (at ex-fact |
600,00 €
|
| |
| |
The Drug Discovery Outlook: Drivers of innovation in the 21st Century
189 pages | Octobre 2000 |
The Drug Discovery Outlook: Drivers of innovation in the 21st Century introduces and analyzes the five key enabling technologies and bioinformatics, which are currently driving pharmaceutical dru |
955,00 €
|
| |
| |
Healthcare In Scotland
52 pages | Mai 2000 |
The Scottish Presentation Includes:- The Structure Of The NHS In Scotland- The Funding Of The NHS In Scotland- Distribution Of The NHS Budget In Scotland- Segmentation Of Expenditure - Total Capital E |
327,00 €
|
| |
| |
The Drug Delivery Outlook to 2005
150 pages | Février 1999 |
Strategic overview : defines and values the market covered in the report, provides a macro analysis of the reasons why the drug delivery sector is growing at current rates and predicts how the c |
795,00 €
|
| |
| |
ePharmacies: Strategic Implications for the Healthcare Industry
230 pages | Mars 2000 |
Increasingly, the pharmaceutical sector is being influenced by the Internet.Are you in a position to:- Predict future shifts in drug prescribing and purchasing behavior?- Anticipate consolidation in b |
955,00 €
|
| |
| |
The Global Parallel Trade Outlook 2001 - 2006: A Country-by-Country Analysis
188 pages | Septembre 2001 |
Global Parallel Trade Outlook 2001: A country-by-country analysis, a new report by Reuters Business Insight, provides a detailed update on the status of parallel trade in the global marketplace.
1 200,00 €
|
|
| |
| |
Pfizer's Recent Takeover
15 pages | Juillet 2002 |
On 15th July 2002, Pfizer announced the acquisition of Pharmacia in a stock-for-stock transaction valued at $60 billion, expanding the company's core strengths in pharmaceuticals and health care.
|
300,00 €
|
| |
| |
|
| |
| Autres secteurs en relation |
|
|
|
| |
|
| |
| |
| Présentation de l'étude de marché - Description & Table des matières |
|
| Global Pharmaceuticals, Biotechnology & Life Sciences |
|
|
Datamonitor's Global Pharmaceuticals, Biotechnology & Life Sciences global pharmaceuticals, biotechnology & life sciences industry. It includes detailed data on market size and segmentation, plus textual analysis of the key trends and competitive landscape, demographic information, and descriptions of the leading companies.
Scope
* Contains an executive summary and data on value, volume and segmentation
* Provides textual analysis of the industry's prospects, competitive landscape and leading companies
* Includes a five-year forecast of the industry
* Supported by the key macroeconomic and demographic data affecting the market
Highlights
* Detailed information is included on market size, measured by both value and volume
* Market shares are covered by manufacturer and/or brand
* Distribution channels are also analyzed
Why you should buy this report
* Spot future trends and developments
* Inform your business decisions
* Add weight to presentations and marketing materials
* Save time carrying out entry-level research
Definition
The global Pharmaceuticals, Biotechnology & Life Sciences industry group is defined as the aggregated revenues of the pharmaceuticals, biotechnolgy and life sciences tools and services markets.
The life sciences tools & services market is comprised of companies enabling the drug discovery, development and production continuum by providing analytical tools, instruments, consumables & supplies, clinical trial services and contract research services. Includes firms primarily servicing the pharmaceutical and biotechnology industries.
The biotechnology industry consists of companies primarily involved in the development, manufacturing or marketing of products based on advanced biotechnology research. The industry value reflects revenues of companies within this industry from product sales, licensing fees, royalties and research funding.
The pharmaceuticals market consists of both ethical and over the-counter (OTC) drugs, but does not include consumer healthcare or animal healthcare. Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors).
All currency conversions used in the report are calculated at constant 2005 annual average exchange rates.
|
|
|
PPLSEN
|
|
|
|
|
